Showing posts with label Orphan Drug Market to Reach $112 Billion in 2017: Bcc Research. Show all posts
Showing posts with label Orphan Drug Market to Reach $112 Billion in 2017: Bcc Research. Show all posts

Tuesday, July 16, 2013

Orphan Drug Market to Reach $112 Billion in 2017: Bcc Research


This BCC Research report also provides a detailed explanation of the current market value, forecast, and growth rate for the next five years for both the biological and non-biological orphan drug segments. BCC Research valued the biological orphan drug segment at $57.7 billion in 2012, and expects the value to reach nearly $71.4 billion in 2017, registering a CAGR (compound annual growth rate) of 4.3%. The report valued non-biological orphan drugs at $28.3 billion in 2012, and forecasts the market to reach $40.8 billion in 2017, after growing at a CAGR (compound annual growth rate) of 7.5%.
Some of the growth drivers for the orphan drugs market discussed by BCC Research in the report include increased research and development, new technology, additional regulatory easing, and new product launches. Additionally, the ability ofpharmaceutical companies to use orphan drugs for off-label uses is also helping in achieving market growth.
This BCC Research report provides insights into the regulations and laws that are allowing the orphan drugs market to grow. BCC Research’s report provides clear and precise guidance on every aspect of the industry.
The study will be beneficial to pharmaceutical and biotechnical companies, research institutes, and physicians.